Financials
Financial year 2025
PHARMACIE de BARRY from Tournai, company number BE0430334263, closed financial year 2025 with a result of € 28,474 after tax. For that financial year PHARMACIE de BARRY recorded a gross margin of € 37,586 and equity of € 21,246. Compared with financial year 2024, the result moved from € 8,844 to € 28,474. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 22, 2026.
€ 21,246
▼ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 28,474
▲ 222% vs 2024
Profit after tax over the fiscal year.
€ 20,890
▲ € 20,257 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 35,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 23
▼ € 4,854 vs 2024
No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.
€ 1,827
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 14,683
▼ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,264
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 128,882 | € 99,285 | € 26,914 | € 37,586 | ▲ 40% |
| Profit after taxes | € 44,542 | € 59,632 | € 8,844 | € 28,474 | ▲ 222% |
| Equity | € 671,910 | € 68,928 | € 27,772 | € 21,246 | ▼ 23% |
| Total debts | € 131,165 | € 261,120 | € 144,684 | € 128,303 | ▼ 11% |
| Cash | € 241,946 | € 157,016 | € 633 | € 20,890 | ▲ € 20,257 |
| Land & buildings | € 21,645 | € 19,037 | € 16,408 | € 14,206 | ▼ 13% |
| Retained profit | € 664,473 | € 61,491 | € 20,336 | € 13,809 | ▼ 32% |
| Dividend | € 44,500 | € 662,614 | € 50,000 | € 35,000 | ▼ 30% |
| Balance sheet total | € 803,075 | € 330,048 | € 172,456 | € 149,549 | ▼ 13% |
| Employees (FTE) | 1 | 1 | - | - |
Key figures of PHARMACIE de BARRY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE de BARRY?
What happened at PHARMACIE de BARRY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 28,474 (▲ 222% vs 2024). filed late Source: NBB ↗
- BLUESTONE SRL became a director. NBB
- NATHALIE MAHIEU became a director. NBB
- New establishment in Tournai. KBO
- Start of the company according to the CBE. KBO
In short
From € 44,542 profit in 2022 to € 28,474 profit in 2025.
Paid € 32,200 in corporate taxes since 2022.
Best year ever: 2023, with € 59,632 profit.
On average € 99,300 of value added per employee in 2023.
A new publication or filing at PHARMACIE de BARRY? We notify you, reason included.
Follow PHARMACIE de BARRYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of PHARMALLIANCE, SWAKOPMUND comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE de BARRYBehind PHARMACIE de BARRY are BLUESTONE SRL and NATHALIE MAHIEU. The shares are held by PHARMALLIANCE (100%) and SWAKOPMUND (99.9%).
Directors
According to the 2025 annual accounts
Director · represented by RANSART PAUL
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PALATINE, LENANS, IMMOLENANS, ANCIAUX, DIGITALE, DELTAPHAR, Europhar +6 more
since 2024
since 2024
Shareholders
100%
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chaussée de Mons(BAR) 21B
7534 Tournai
Chaussée de Mons(BAR) 21 B
7534 Tournai
Active since 11 February 1987
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0430.334.263
- VAT number
- BE 0430.334.263
- Registered office
- Chaussée de Mons(BAR) 21B, 7534 Tournai
- Names & denominations
- PHARMACIE de BARRY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 January 1987
- Peppol
- Active · Active since 22 Apr 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers